Publications by authors named "Jonas Scheid"

Claim this Profile
F
FLT3-ITD Induces CMTM6 and Enhances Immune Escape in Acute Myeloid Leukemia.
Melissa Zwick, Bastian Zinkel, Corinna Spohr, Tamina Rückert, Sebastian Halbach, Jonas Scheid

Cancer Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MHCquant2 refines immunopeptidomics tumor antigen discovery.
Jonas Scheid, Steffen Lemke, Naomi Hoenisch-Gravel, Anna Dengler, Timo Sachsenberg

Genome Biol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PCI-DB: a novel primary tissue immunopeptidome database to guide next-generation peptide-based immunotherapy development.
Steffen Lemke, Marissa L Dubbelaar, Patrick Zimmermann, Jens Bauer, Annika Nelde, Jonas Scheid

J Immunother Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TIMSRescore: A Data Dependent Acquisition-Parallel Accumulation and Serial Fragmentation-Optimized Data-Driven Rescoring Pipeline Based on MSRescore.
Arthur Declercq, Robbe Devreese, Jonas Scheid, Caroline Jachmann, Tim Van Den Bossche

J Proteome Res· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping naturally presented T cell antigens in medulloblastoma based on integrative multi-omics.
Julia Velz, Lena K Freudenmann, Gioele Medici, Marissa Dubbelaar, Malte Mohme, Jonas Scheid

Nat Commun· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proceedings of the EuBIC-MS developers meeting 2023.
Pedro Beltrao, Tim Van Den Bossche, Ralf Gabriels, Tanja Holstein, Tobias Kockmann, Jonas Scheid

J Proteomics· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TOF mass spectrometry-based immunopeptidomics refines tumor antigen identification.
Naomi Hoenisch Gravel, Annika Nelde, Jens Bauer, Lena Mühlenbruch, Sarah M Schroeder, Jonas Scheid

Nat Commun· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNMT and HDAC inhibition induces immunogenic neoantigens from human endogenous retroviral element-derived transcripts.
Ashish Goyal, Jens Bauer, Joschka Hey, Dimitris N Papageorgiou, Ekaterina Stepanova, Jonas Scheid

Nat Commun· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency.
Jonas S Heitmann, Claudia Tandler, Maddalena Marconato, Annika Nelde, Timorshah Habibzada, Jonas Scheid

Nat Commun· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma.
Jens Bauer, Natalie Köhler, Yacine Maringer, Philip Bucher, Tatjana Bilich, Jonas Scheid

Nat Commun· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA-DR Presentation of the Tumor Antigen MSLN Associates with Clinical Outcome of Ovarian Cancer Patients.
Christian M Tegeler, Jonas Scheid, Hans-Georg Rammensee, Helmut R Salih, Juliane S Walz

Cancers (Basel)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis